ION356
- Generic Name
- ION356
Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Participants With Pelizaeus Merzbacher Disease (PMD)
- First Posted Date
- 2023-11-29
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Ionis Pharmaceuticals, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT06150716
- Locations
- 🇳🇱
Ionis Investigative Site, Amsterdam, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath